• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCL7 信号在肿瘤微环境中的作用。

CCL7 Signaling in the Tumor Microenvironment.

机构信息

Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Adv Exp Med Biol. 2020;1231:33-43. doi: 10.1007/978-3-030-36667-4_4.

DOI:10.1007/978-3-030-36667-4_4
PMID:32060844
Abstract

The tumor microenvironment is the primary location in which tumor cells and the host immune system interact. There are many physiological, biochemical, cellular mechanisms in the neighbor of tumor which is composed of various cell types. Interactions of chemokines and chemokine receptors can recruit immune cell subsets into the tumor microenvironment. These interactions can modulate tumor progression and metastasis. In this chapter, we will focus on chemokine (C-C motif) ligand 7 (CCL7) that is highly expressed in the tumor microenvironment of various cancers, including colorectal cancer, breast cancer, oral cancer, renal cancer, and gastric cancer. We reviewed how CCL7 can affect cancer immunity and tumorigenesis by describing its regulation and roles in immune cell recruitment and stromal cell biology.

摘要

肿瘤微环境是肿瘤细胞和宿主免疫系统相互作用的主要场所。肿瘤的周围有许多生理、生化和细胞机制,由各种细胞类型组成。趋化因子及其受体的相互作用可以招募免疫细胞亚群进入肿瘤微环境。这些相互作用可以调节肿瘤的进展和转移。在本章中,我们将重点介绍趋化因子(C-C 基序)配体 7(CCL7),它在包括结直肠癌、乳腺癌、口腔癌、肾癌和胃癌在内的各种癌症的肿瘤微环境中高度表达。我们通过描述 CCL7 在招募免疫细胞和基质细胞生物学方面的调节和作用,综述了它如何影响癌症免疫和肿瘤发生。

相似文献

1
CCL7 Signaling in the Tumor Microenvironment.CCL7 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2020;1231:33-43. doi: 10.1007/978-3-030-36667-4_4.
2
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.癌症微环境中的趋化因子及其在癌症免疫治疗中的相关性。
Nat Rev Immunol. 2017 Sep;17(9):559-572. doi: 10.1038/nri.2017.49. Epub 2017 May 30.
3
Interleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer.白细胞介素-12免疫调节可延缓卵巢癌致死性腹膜疾病的发生。
J Interferon Cytokine Res. 2016 Jan;36(1):62-73. doi: 10.1089/jir.2015.0049. Epub 2015 Oct 2.
4
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.促炎趋化因子-趋化因子受体相互作用在尤文肉瘤微环境中决定 CD8(+) T 淋巴细胞浸润并影响肿瘤进展。
J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10.
5
Crucial biological functions of CCL7 in cancer.CCL7在癌症中的关键生物学功能。
PeerJ. 2018 Jun 14;6:e4928. doi: 10.7717/peerj.4928. eCollection 2018.
6
Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors.趋化因子(C-C 基序)配体 7(CCL7)及其受体(CCR2)表达对结直肠癌行为的影响。
Int J Mol Sci. 2019 Feb 5;20(3):686. doi: 10.3390/ijms20030686.
7
CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer.CCL7 招募 cDC1 以促进抗肿瘤免疫并促进非小细胞肺癌的检查点免疫治疗。
Nat Commun. 2020 Nov 30;11(1):6119. doi: 10.1038/s41467-020-19973-6.
8
Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.趋化因子异源复合物与癌症:肿瘤免疫的新篇章。
Front Immunol. 2018 Sep 25;9:2185. doi: 10.3389/fimmu.2018.02185. eCollection 2018.
9
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.趋化因子调节肿瘤发生、转移和免疫治疗反应中的免疫监视。
Front Immunol. 2019 Feb 27;10:333. doi: 10.3389/fimmu.2019.00333. eCollection 2019.
10
Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.癌症免疫治疗中趋化因子导向的肿瘤微环境调节
Int J Mol Sci. 2021 Sep 10;22(18):9804. doi: 10.3390/ijms22189804.

引用本文的文献

1
The Role of Chemokine (C-C Motif) Ligand 7 (CCL7) in Hepatocellular Carcinoma: Expression, Function, and Mechanisms.趋化因子(C-C基序)配体7(CCL7)在肝细胞癌中的作用:表达、功能及机制
Cancer Med. 2025 Mar;14(5):e70701. doi: 10.1002/cam4.70701.
2
Inflammatory biomarkers and therapeutic potential of milk exosome-mediated CCL7 siRNA in murine intestinal ischemia-reperfusion injury.牛奶外泌体介导的CCL7小干扰RNA在小鼠肠道缺血再灌注损伤中的炎症生物标志物及治疗潜力
Front Immunol. 2025 Jan 20;15:1513196. doi: 10.3389/fimmu.2024.1513196. eCollection 2024.
3
Tumor Microenvironment in Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis.
透明细胞肾细胞癌中的肿瘤微环境:综合分析
Iran J Public Health. 2024 Nov;53(11):2538-2550. doi: 10.18502/ijph.v53i11.16957.
4
LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets.LINC01094:癌症进展调控及治疗靶点中的关键长链非编码RNA。
Heliyon. 2024 Sep 7;10(18):e37527. doi: 10.1016/j.heliyon.2024.e37527. eCollection 2024 Sep 30.
5
Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis.基于免疫基因组图谱分析的透明细胞肾细胞癌预后预测
Heliyon. 2024 Aug 13;10(16):e36156. doi: 10.1016/j.heliyon.2024.e36156. eCollection 2024 Aug 30.
6
Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.基于氧化应激相关基因鉴定具有不良预后和高免疫浸润的新型胶质母细胞瘤多形性分子亚型。
Medicine (Baltimore). 2024 Feb 16;103(7):e35828. doi: 10.1097/MD.0000000000035828.
7
Investigating Vitreous Cytokines in Choroidal Melanoma.脉络膜黑色素瘤中玻璃体细胞因子的研究
Cancers (Basel). 2023 Jul 21;15(14):3701. doi: 10.3390/cancers15143701.
8
Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR-487a-5p promotes melanoma oligo- to poly-metastatic progression.S100A11 分泌蛋白与外泌体 miR-487a-5p 协同抑制 NUDT21 促进黑素瘤寡转移至多转移进展。
Mol Oncol. 2023 Dec;17(12):2743-2766. doi: 10.1002/1878-0261.13480. Epub 2023 Jul 1.
9
Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients.鉴定一种用于预测骨肉瘤患者预后的新型MYC靶基因集特征。
Front Oncol. 2023 Jun 5;13:1169430. doi: 10.3389/fonc.2023.1169430. eCollection 2023.
10
HIF1α/CCL7/KIAA1199 axis mediates hypoxia-induced gastric cancer aggravation and glycolysis alteration.低氧诱导因子1α/趋化因子配体7/KIAA1199轴介导缺氧诱导的胃癌恶化和糖酵解改变。
J Clin Biochem Nutr. 2023 May;72(3):225-233. doi: 10.3164/jcbn.22-48. Epub 2023 Jan 13.